Introduction
Echinacea has a rich tradition of use by First Nations Peoples of the North American plains [1] . Echinacea use was quickly adopted by European settlers in the 19th century [2] and is now one of the top-selling herbs in natural products' market surveys in North America [3, 4] . The genus is native to the prairies of central and southeastern United States, extending north to southeastern Saskatchewan and southern Manitoba in Canada [2] . The taxonomy of Echinacea was recently reassessed using morphometric and AFLP analysis which provided evidence for four species and several varieties [5] . The two species commonly used as medicine are Echinacea purpurea (L.) Moench and Echinacea pallida (Nutt.) Nutt. var. angustifolia (DC.) Cronquist (syn. E. angustifolia) [5, 6] .
Medicinal extracts
In vivo and in vitro pharmacological investigations have shown immunomodulatory effects by Echinacea [12, 22] which may account for the efficacy of using Echinacea to treat and prevent colds and flu [7] . However, the modes of action of Echinacea as an antifungal and for topical applications have not been examined in detail. Our objective was to study possible modes of antifungal activity of Echinacea extracts. We investigated eight different ethanolic extracts of E. purpurea and E. angustifolia for potential phototoxicity and light-independent (dark) toxicity to Saccharomyces cerevisiae, i.e., a total of 16 treatments. To study the possible mode of action of Echinacea, we used a set of 4,600 viable gene deletion mutants of S. cerevisiae, each with a defined deletion of a characterized or putative gene. The mutants were grown with and without each treatment to provide a view of the chemical-genetic interactions and identify pathways affected by exposure to Echinacea extracts.
Our rationale for the above approach was three-fold. First, we investigated the mode of antifungal activity in extracts of all E. purpurea and E. angustifolia parts based on the traditional usage outlined above. Second, dark and near-UV-light-enhanced antifungal activity of ethanolic extracts from these plants is well-established, although the specific activities of the dozens of lipophilic compounds in these extracts is largely unknown [11, 23] . Thus, we looked for consensus activities among diverse ethanol extracts of Echinacea with and without UV light activation. Third and finally, the chemical-genomic profiles of crude extracts can closely resemble those of the active, pure, constituent compounds [24] . Determination of mode of action by crude extracts may therefore help guide subsequent efforts to identify the active compound(s) in complex mixtures.
The notable trend in our Echinacea gene deletion array (GDA) data sets was an abundance of supersensitive yeast mutants with defects in cell wall-associated functions, suggesting that Echinacea extracts perturb fungal cell wall biogenesis/functions. Subsequently, we tested whether fungi grown in the presence of sub-inhibitory levels of Echinacea were more sensitive to sonication-based cell wall disruption.
Materials and methods
The series of steps employed in this study are illustrated in Fig. 1 . The following sections describe the procedures in further detail.
Echinacea sources
Echinacea purpurea (U Ottawa voucher no. 010502-18) and E. angustifolia (U Ottawa # 010410-12 and 020607-01) plant materials were obtained from North American commercial growers and classified according to the most recent taxonomic revision [5] . Eight ethanol extracts (55% EtOH or 70% EtOH) were prepared using root, leaves stems, leaves stems flowers (herb) and flowers exactly as described previously [10, 25] , using an accelerated solvent extraction system (DIONEX). All fractions were concentrated at 30°C in a rotary-evaporator and adjusted to 50 ml in the appropriate solvent and stored in the dark at 20°C or kept as dried powder until use.
Fungal strains and MIC assays
Wildtype (S288C, MAT SUC2 mal mel gal2 CUP1 flo1 flo8-1 hap1) and mutant strains of S. cerevisiae, and Cryptococcus neoformans (Ontario Ministry of Health, OMH # FR2704) were grown in either YPD medium (1% yeast extract, 2% peptone, 2% glucose) or SCM (synthetic complete medium, 2% glucose, 0.67% yeast nitrogen base) with or without 2% agar and supplements as required. For the MIC assays strains were grown to mid-log phase in YPD broth, adjusted to OD600 0.8 and diluted to obtain 10 3 CFU/mL (colony forming units/ml) before aliquoting 100 cells in 100 μl YPD into each well of a 96-well sterile plate. Echinacea extracts were serially diluted across the wells with the last column serving as a drug-free control. Each fraction was tested under two conditions, i.e., following UV light irradiation (10 W/m 2 for 2 h using three 20 W black-light blue tubes, 320-400 nm range) and without UV light irradiation (dark treatment), for which plates were wrapped in aluminum foil. The microtiter plates from both UV and dark treatments were then incubated in the dark at 30ºC and monitored at 48 h. Mean MIC values were based on optical density readings (OD600, Spectra Max 340PC, Molecular Devices, Sunnyvale CA) and calculated from multiple trials (n 3) as the concentration at which there was 80% growth reduction in comparison to wells with no inhibitor present.
Gene deletion array (GDA) analysis
Chemical-genomic profiling of Echinacea extracts was done using a yeast GDA as described by Parsons et al. [24] . The method is based on comparing the size of the colonies formed by yeast gene deletion strains with and without a semi-inhibitory concentration of the target drug incorporated in the medium. We used a set of haploid S. cerevisiae strains representing 4600 gene mutants in the background strain BY4741, a derivative of S288C [26] . Echinacea extracts were added to 55°C molten YPD agar medium at a concentration that was 80% of the MIC. YPD agar plates without (control) and with Echinacea extract (experimental) were inoculated by hand pinning sets of 384 (16 × 24) mutant strains per plate with a 384-floating pin replicator. S288C (wild-type) and YLR338W (deletion of OPI9, Table 1 ), and C. neoformans were each grown overnight at 30°C with shaking in 1 ml YPD broth with E. purpurea 70% EtOH root extract (experimental) or with an equivalent volume of 70% EtOH (control). The extract concentrations used was 50% of the MIC values for the respective strains. The overnight cultures were diluted by addition of 4 ml of YPD EtOH (control) or YPD extract (experimental) and incubated for an additional 1 h at 30°C. Cultures were adjusted to 1.0 × 10 7 cells/ml, aliquoted into 1.5 ml epitubes and placed on ice. Aliquots (1 ml) of control and experimental cultures were sonicated using an intensity setting of 3 and a 3 mm microtip (Vibra-Cell VC250, Sonics & Materials, Connecticut, USA) for either 0 or 2.15 minutes at room temperature and then placed back on ice. Cultures were vortexed briefly and then 10-times serial diluted to 10 3 cells/ml. Ten μl of each dilution was then spotted onto YPD agar plates followed by 48 h incubation at 30°C before colony counts were performed.
A second variation of this sonication-based assay used milder Echinacea exposure conditions and investigated possible dose response effects of Echinacea extracts on yeast cell walls. For this assay, strain S288C was incubated at 30°C at 150 rpm to an early log phase (OD600 0.2). At this point, a 70% EtOH extract of E. purpurea roots was added to two aliquots of cells at 10% and 20% of the MIC concentration. A carrier control was also established by incubating an aliquot of cells with an equivalent volume of Following UV light irradiation (as described above) or dark treatments, the plates were incubated for 1-2 days at 30°C, photographed with a high-resolution digital camera (Hewlett Packard PhotoSmart 735 digital camera), and analyzed as described in detail by Memarian et al. [27] . Briefly, for both experimental and control plates, the size of each colony was digitally determined and compared to the average colony size for all colonies on the plate. Mutant colonies that are sensitive to a given treatment are smaller than the average of colony sizes on the experimental plate but are not smaller than the average of colony sizes on the control plate. After this normalization for mutation-associated colony size differences and overall growth inhibition due to the treatment, we obtained for each extract a ranked list of most to least sensitive mutants. The top 5% ( 230) most sensitive mutants were then selected from each of the 16 treatments (light and dark treatments with each of the 8 extracts). We then selected the subset of mutants that were supersensitive to five or more extract treatments to look for an overall mode of antifungal action by Echinacea.
Cell wall disruption assays
Two variations of a sonication-based assay [28] were used to test whether Echinacea exposure compromises the structure/function of yeast cell walls. The first involved a relatively long (overnight) exposure to relatively high concentrations of Echinacea extract. S. cerevisiae strains 70% EtOH. The cultures were then incubated for 4.5 h at 30°C with shaking, after which aliquots of each sample were placed on ice before sonication for times ranging from 40-85 s (60% amplitude, 3 mm microtip, VibraCell VCX130). A drop plate assay was then performed as described above. The sensitivity of each sample was expressed as a cell survival percentage (#cells surviving with sonication treatment/# cells surviving no-sonication treatment 100).
The effects of Echinacea extract on yeast cell walls was also examined by fluorescence microscopy. S. cerevisiae S288C was grown to mid-log phase in SCM and a 70% EtOH extract of E. purpurea roots was added at 40% of the MIC. A carrier control was likewise established. The cells were incubated for 4 h at 30°C with shaking prior to a mild sonication treatment on ice (30 s, 60% amplitude, Vibra-Cell VCX130, 3 mm microtip). Cultures were stained with 0.2 μg/μl of calcofluor white (American Cyanamid, Bound Brook, NJ) and immediately viewed by fluorescence microscopy (Axio Imager, Carl Zeiss, Toronto, ON).
At least 200 cells were examined for each treatment from 5 randomly selected fields and evaluated for cell wall damage.
Results

Twenty-three yeast mutants exhibit high Echinacea sensitivity
Antifungal activity that is enhanced by near-UV exposure is well-established for Echinacea extracts [11, 23] . The specific active compound(s) and their mode(s) of action in these extracts are largely unknown. To investigate antifungal mode of action of Echinacea, we looked for patterns among chemical-genomic interaction profiles obtained by subjecting an array of haploid yeast deletion mutants to inhibitory Echinacea treatments. We selected diverse treatments ( Fig. 1 ; different EtOH extracts, plant parts, light and dark activity, and two traditionally relevant Echinacea species) in an attempt to identify over-riding patterns of Echinacea antifungal activities. YOR323C Catalyzes the second step in proline biosynthesis 2, 3 All Echinacea extracts tested had antifungal activity against the wild type S. cerevisiae S288C. MIC values ranged from 0.3-5.0 mg/ml depending on source species, plant part and extract preparation (Fig. 1) . Overall, 70% EtOH extracts were more effective than 55% EtOH extracts at inhibiting the growth of yeasts (means of 1.6 and 3.3 mg/ml, respectively; P 0.02, paired t-test). In concordance with previous studies (reviewed in [11]), lightmediated antifungal activity (phototoxicity) was evident as lower MIC values with near-UV light treatments (300-400 nm) as compared to dark treatments (means of 1.7 and 2.6 mg/ml, respectively; P 0.01, paired t-test). Previous studies indicate that the phototoxicity of Echinacea ethanol extracts is likely associated with the presence of polyacetylenes and alkamide compounds, some of which are known to also have dark activity [11, 25] . These compounds may be prone to oxidative degradation depending on the storage conditions and extract composition [29] . To control for the possibility of degradation of antifungal compounds and for variation in inhibitory characteristics of different extracts, we used dried or freshly prepared extracts, and adjusted extract concentrations for subsequent experiments based on inhibitory levels of a given fungal strain and extract combination (e.g., 80% of MIC value).
To examine chemical-genetic interactions that may provide insights into Echinacea antifungal mode of action, genetic profiles for each of the 16 different treatments were generated. For this, the effect of each treatment on gene deletion strains was determined by digital imaging and comparison of colony sizes on media with and without extract added at 80% of the MIC (Fig. 1) . Examples of three supersensitive mutant colonies from GDA experiments are shown in Fig. 2 . Mutants were subsequently ordered based on percent reduction in colony size and 5% of the 4600 mutants that showed greatest reduction in growth on experimental plates as compared to carrier control plates were designated as supersensitive mutant strains for each treatment (see Supplementary Table S1 in the online version of the paper). We next compared these most sensitive mutant strains from each treatment and selected ones that were among the supersensitive in five or more treatments. Based on binomial proportions, it is unlikely (P 0.05) that a given mutant within this most sensitive 5% group would occur in five or more treatments by chance. From this we obtained the consensus set of 23 Echinacea-sensitive mutants listed in Table 1 .
Based on subsequent MIC determinations with one of the extracts, E. purpurea 70% EtOH root extract, this group of 23 mutant strains was significantly more sensitive than was the S288C wild-type strain ( Fig. 3 ; 1-tailed t-test P values of 0.01 { UV} and 0.004 {dark}). MIC values were also correlated with colony size reductions obtained from GDA analyses in that mutants with relatively smaller colony sizes in GDA experiments were also most sensitive to Echinacea based on MIC determinations (data not shown). These MIC determinations validated the quantitative results of our GDA experiments. 
GDA analysis suggests Echinacea extracts disrupt cell wall functions
Of the 23 Echinacea-sensitive mutants, 16 have known functional defects in cell wall, transcription, protein tagging or amino acid biosynthesis, and seven are in genes of unknown function. The significant pattern to emerge from this analysis is that of the 16 known function mutations, 10 are involved in cell wall integrity/structure. We used the Yeast Features (YF) software tool [30] to assess the statistical significance of shared features among the set of 23 yeast proteins. Based on YF, the probability that these common cell wall features would occur together in our data set by chance is unlikely (P values are less than 4 10 -3 for all five cell wall-related features; Table 2 ). Overall, these data indicate that Echinacea extracts primarily form chemical interactions with cell wall-associated genes or gene products, either directly or indirectly, and exert their antifungal activity by affecting cell wall function(s). This hypothesis was further tested using sonication-based assays.
Combination of sonication with Echinacea extracts greatly increases yeast cell death
We assessed whether treatment of S. cerevisiae and Cryptococcus neoformans with 70% EtOH extracts of E. purpurea roots perturbs cell wall function using sonication assays. The basis of these assays is that a strain that carries a cell wall defect, or that is exposed to a chemical that interferes with cell wall biogenesis, will be more likely to sustain cell wall damage and lyse during exposure to ultrasound [28] . Table 3 shows results from sonication experiments performed using yeast wild type S288C and strain YLR338W that has a mutation inferred to compromise cell wall function (Table 1) , along with an isolate of C. neoformans, a basidiomycete yeast. The fungal strains were cultured without or with 70% EtOH extract of E. purpurea roots at 50% of the MIC, a concentration that resulted in 20% growth rate reduction of the respective strains. While some sensitivity to sonication was evident when each strain was grown in the absence of Echinacea extract, the combination of sonication and Echinacea treatments resulted in at least a 200-fold reduction in colony forming units (CFUs), indicating that exposure to Echinacea extract significantly sensitized yeast cells to disruption by sonication. The sensitivity to Echinacea extract was most pronounced in the cell wall mutant, YLR338W ( 2000× reduction in CFU, Table 3 ). This, and that both ascomycete and basidiomycete yeasts had increased sonication sensitivities following extract exposure, suggests that a general mode of Echinacea antifungal activity is through perturbation of cell wall function. Fig. 4 shows similar trends when S. cerevisiae is exposed to milder Echinacea extract treatments. Extract   Fig. 3 Relative sensitivity of the 23 supersensitive mutant strains to one of the extracts used in GDA screens. MIC values were determined with the 70% EtOH E. purpurea root extract. Strains are numbered as in Table 1 and the wildtype S288C strain is at left. MICs were determined with (triangles) and without (dots) exposure to UV light. Plotted for each strain is the value, MIC mut /MIC con , where MIC mut and MIC con are the MIC values of mutant strain and S288C, respectively. Mutant strains sensitive to this extract, relative to S288C, are positioned below the horizontal line. Table 2 Cell wall functions of selected deletion strains supersensitive to Echinacea extracts. Identified functions include cell wall organization and biogenesis, decreased resistance to calcofluor white, -1,6-mannosyltransferase complex, increased levels of chitin, and cell budding concentrations used in these experiments were set to 10% and 20% of the MIC values and exposure was over a 4.5 h period. The figure plots percent survival of sonicated cells over non-sonicated cells with and without the addition of Echinacea extract, and provides evidence of a dosedependent response whereby increasing concentrations of Echinacea result in greater sensitivity to cell wall disruption by sonication. The results of the above sonication experiments supported the hypothesis that yeast cell wall functions are compromised by exposure to Echinacea extracts.
Finally, direct microscopic examination of S. cerevisiae cells provided further support for the above hypothesis (Fig. 5) . A significantly greater frequency of cells had cell wall lesions evident when treated with Echinacea extract prior to mild sonication, in comparison to cells that were not exposed to the extract (P 0.001, ttest of arcsine square root transformed frequencies).
Discussion
Using an ordered set of S. cerevisiae gene deletion mutants we explored the molecular mechanism of Echinacea extracts antifungal activity in terms of potential target proteins and pathways in yeast cells. The significant trend emerging from the analysis of the 23 deletion mutants that were supersensitive to 5 or more Echinacea treatments was one of impaired cell wall functions. Previously, Towers et al. [31] suggested that the increased near-UV-light-mediated inhibitory activity of phototoxic alkamides and polyacetelenes could be attributed to the production of single oxygen and peroxidation of cell membranes in the target organism. This proposed mechanism is intriguing given the results of our GDA analysis and the functional association of the cell membrane in fungal cell wall biogenesis. Table 2 lists five cell wall functions that are compromised in mutants found to be most sensitive to Echinacea extracts. The associated mutations likely perturb cell wallassociated processes such as the organization and synthesis of the -1,6-mannosyltransferase complex. For example, the deletion strain KRE6 was shown to have significantly reduced growth in response to six of the 16 Echinacea treatments (Supplementary Table S1 ). Strains with a Kre6p deficiency show reduction in -1,6-glucan synthase and decreased levels of alkaline soluble proteins in the S. cerevisiae cell wall [32] . In addition, it was shown that mutations affecting Kre6p cause synthetic lethality when expressed in gas1 mutant cells [33] . Note that the GAS1 deletion strain was also identified in our set of 23 mutants (Table 1) . GAS1 encodes a glycosylphosphatidylinositol (GPI)-anchored protein that is located in yeast plasma membrane [34] . The disruption in GAS1 causes leakage of ß-1,3-glucan into the medium, hypersensitivity to calcofluor white and an increased chitin content in the cell wall [34] [35] [36] . Our identification of both GAS1 and KRE6 mutants among the supersensitive mutants suggests that a parallel cell wall-associated pathway is negatively affected by Echinacea extracts.
The identification of the two genes MNN10 and HOC1 among the most sensitive strains in the present study provides additional evidence that Echinacea compounds interfere with fungal cell wall processes. Deletion of Mnn10p results in defective mannan biosynthesis in vivo and upregulation of other cell wall components, especially chitin [37] [38] [39] . It has also been shown that HOC1 encodes a subunit of a Golgi-localized complex in mannosyltranferase and Hoc1p has a regulatory role in determining mannan polymer size [40] .
Cell wall integrity is likely to be critical during budding. Previous studies suggested that Bem2p, also listed in Table 1 , is important for cytoskeleton organization as well as cell wall maintenance in yeast [41] . In yeast, genes encoding Rho GTPases such as RHO1, which is activated by Bem2p, play an essential role in the regulation of cell wall synthesis and cytoskeleton organization including bud emergence and growth [42, 43] . Interestingly, BEM2 is involved in bud emergence and there is also a direct genetic interaction between BEM2 and RHO1 in the same pathway that regulates microfilament-mediated polarized cell growth [41] . Another important consideration is that Echinacea extracts affect some other functions that may indirectly cause alterations in cell wall synthesis. Of particular interest is the finding that deletion of the ubiquitin gene, URM1, results in increased sensitivity to Echinacea extracts, as ubiquitin marks transmembrane proteins for removal from the membrane [44, 45] .
Sonication is used to physically disturb yeast cell walls and membranes by ultrasound-induced cavitation [28, 46] . Sonication assays provided further evidence that Echinacea extracts perturb fungal cell wall functions. Viability assays and direct microscopic examination indicated that there is a significant increase in sonication-associated cell death and lysed cell frequencies in samples exposed to E. purpurea root extracts. Similar cell wall disruption assays may identify additional genes that contribute to cell wall function in the set of nine unknown function mutants listed in Table 1 .
Fungi are recognized as a sister taxon to animals and share many biochemical and structural cellular features with plants. Therefore, the development of antifungal compounds that inhibit fungal growth without harming the plant or animal host is a challenge. However, one of the defining characteristics of fungi is the structure and makeup of the cell wall. As a result, the cell wall and the cell wall integrity pathways are among the most desirable targets in the development of new, highly specific, antifungal drugs [47] [48] [49] . This study provides compelling evidence that the fungal cell wall is a major target of Echinacea extracts and may thus explain the utility of this phytomedicine in traditional treatments of mycoses. 
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